<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2802">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04647747</url>
  </required_header>
  <id_info>
    <org_study_id>SHYCOV2020</org_study_id>
    <nct_id>NCT04647747</nct_id>
  </id_info>
  <brief_title>Silent Hypoxia and Awake Proning in COVID-19 Patients</brief_title>
  <acronym>SHYCOV</acronym>
  <official_title>Silent Hypoxia and Awake Proning in COVID-19 Patients: Home Monitoring and Self-Reporting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ostfold Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ostfold Hospital Trust</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Investigators want to examine patients infected with SARS-CoV-2 for the phenomenon&#xD;
      &quot;Silent Hypoxia&quot;, which is clinically significant hypoxia without corresponding degree of&#xD;
      dyspnea. The patient population is infected individuals without any serious symptoms and is&#xD;
      at home. The participants will be equipped with a pulse oximeter and a PEF-measurement&#xD;
      device. Four times daily the participants will register saturation, degree of dyspnea and&#xD;
      PEF. If the participants experience desaturation or increasing dyspnea, physiotherapy is to&#xD;
      be performed, and if that doesn't relieve symptoms or increase oxygen saturation, the&#xD;
      hospital should be contacted for admission. The first part of this study is a feasibility&#xD;
      study, and if found feasible, the investigators will expand the study to more participants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 30, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients who manage to perform daily measurements of SpO2</measure>
    <time_frame>January 30, 2021</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence rate of silent hypoxia in non-hospitalized COVID-19</measure>
    <time_frame>January 30, 2021</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Association between silent hypoxia and other subjective and objective measurements of disease severity</measure>
    <time_frame>January 30, 2021</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of a self-managed physiotherapy program on alleviating hypoxia</measure>
    <time_frame>January 30, 2021</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of persistent silent hypoxia episode per patients</measure>
    <time_frame>January 30, 2021</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of silent hypoxia episode per patients</measure>
    <time_frame>January 30, 2021</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of hospital admission and ICU admission</measure>
    <time_frame>January 30, 2021</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of thromboembolic event in outpatients diagnosed with COVID-19</measure>
    <time_frame>January 30, 2021</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Covid19</condition>
  <condition>Hypoxemia</condition>
  <arm_group>
    <arm_group_label>Self measurement of peripheral saturation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participant will be equipped with a pulse oximeter and perform saturation measurements.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Self measurement with pulse oximeter</intervention_name>
    <description>Participant will measure peripheral saturation at home, conduct physiotherapy if desaturation occurs, and contact hospital if desatuation persists</description>
    <arm_group_label>Self measurement of peripheral saturation</arm_group_label>
    <other_name>Lung physiotherapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Non dyspneic (NRS =/&lt; 1) patients with positive SARS-CoV-2 test&#xD;
&#xD;
          -  Age 18 - 80 years&#xD;
&#xD;
          -  Patients managed at home&#xD;
&#xD;
          -  Inclusion within 72 hours from positive test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic hypoxia (SpO2 &lt; 93 %) and/or first measured SpO2 &lt; 93 %&#xD;
&#xD;
          -  Admitted to hospital for COVID-19 prior to inclusion&#xD;
&#xD;
          -  Unable to perform pulse oximetry&#xD;
&#xD;
          -  Unable to perform physiotherapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ostfold Hospital</name>
      <address>
        <city>Sarpsborg</city>
        <state>Gr√•lum</state>
        <zip>1714</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans Joakim Myklebust-Hansen, MD</last_name>
      <phone>004797501765</phone>
      <email>hans.joakim.hansen@so-hf.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>November 27, 2020</study_first_submitted>
  <study_first_submitted_qc>November 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 1, 2020</study_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ostfold Hospital Trust</investigator_affiliation>
    <investigator_full_name>Hans Joakim Myklebust-Hansen</investigator_full_name>
    <investigator_title>Konstituert Overlege, Akuttseksjonen</investigator_title>
  </responsible_party>
  <keyword>Silent Hypoxia</keyword>
  <keyword>Lung Physiotherapy</keyword>
  <keyword>Home Monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

